NovelStem International Corp. (NSTM)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:15PM EST
| Previous Close | 0.3100 |
| Open | 0.2799 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.2799 - 0.3100 |
| 52 Week Range | 0.1300 - 0.3500 |
| Volume | |
| Avg. Volume | 14,230 |
| Market Cap | 7.019M |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | 1.12 |
| EPS (TTM) | 0.2760 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Apr. 02, 2018 |
| 1y Target Est | N/A |
- Newsfile
NovelStem Announces NewStem, Ltd. Was Selected by Illumina for its Global Illumina Accelerator
Boca Raton, Florida and Jerusalem, Israel--(Newsfile Corp. - September 20, 2021) - NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on the stem cell-based technology platform developed by 30%-owned Israel-based, NewStem, Ltd., announced that NewStem, along with six other genomic companies, was selected by Illumina for its global Illumina Accelerator. Illumina Accelerator is a company creation engine that focuses on partnering with and building companies with unique
